CEFUROXIME + CLAVULANATE in pharma franchise in Gujarat

CEFUROXIME + CLAVULANATE in PCD pharma franchise in Kolkata

CEFUROXIME + CLAVULANATE in top pharma company in Nagpur

CEFUROXIME + CLAVULANATE in pcd pharma supplier in Agartala

CEFUROXIME + CLAVULANATE in phama franchise company in india
CEFUROXIME + CLAVULANATE in phama distributor in Kohima

Home/Products /cefuroxime-250-mg-clavulanate-125-mg-tablet

Cefuzrom CV 250 Tablet

Composition : CEFUROXIME 250 MG + CLAVULANATE 125 MG

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*1*10

Price : ₹350/-

Cefuzrom CV 250 Tablet is a broad-spectrum antibiotic used to treat bacterial infections effectively. It combines Cefuroxime (250 mg), a second-generation cephalosporin antibiotic, with Clavulanate (125 mg), a beta-lactamase inhibitor that enhances the antibiotic’s effectiveness against resistant bacteria. This combination works synergistically to eliminate infections caused by a wide range of bacteria by preventing bacterial cell wall synthesis and inhibiting bacterial resistance mechanisms.

Cefuzrom CV 250 is particularly effective against respiratory tract infections, urinary tract infections (UTIs), skin and soft tissue infections, sinusitis, tonsillitis, bronchitis, pneumonia, and other bacterial infections. The addition of Clavulanate ensures that bacteria producing beta-lactamase enzymes do not neutralize the antibiotic, making it more potent against resistant strains.

This formulation is widely prescribed for adults and children, ensuring quick relief and faster recovery from infections. It is generally well-tolerated when taken as directed, with a short treatment duration and high efficacy. It is advisable to complete the full course of the medication as prescribed by a healthcare professional to prevent antibiotic resistance and ensure complete bacterial eradication.

Read More

About the Product

Cefuzrom CV 250 Tablet is a broad-spectrum antibiotic used to treat bacterial infections effectively. It combines Cefuroxime (250 mg), a second-generation cephalosporin antibiotic, with Clavulanate (125 mg), a beta-lactamase inhibitor that enhances the antibiotic’s effectiveness against resistant bacteria. This combination works synergistically to eliminate infections caused by a wide range of bacteria by preventing bacterial cell wall synthesis and inhibiting bacterial resistance mechanisms.

Cefuzrom CV 250 is particularly effective against respiratory tract infections, urinary tract infections (UTIs), skin and soft tissue infections, sinusitis, tonsillitis, bronchitis, pneumonia, and other bacterial infections. The addition of Clavulanate ensures that bacteria producing beta-lactamase enzymes do not neutralize the antibiotic, making it more potent against resistant strains.

This formulation is widely prescribed for adults and children, ensuring quick relief and faster recovery from infections. It is generally well-tolerated when taken as directed, with a short treatment duration and high efficacy. It is advisable to complete the full course of the medication as prescribed by a healthcare professional to prevent antibiotic resistance and ensure complete bacterial eradication.

Common side effects may include nausea, diarrhea, abdominal pain, headache, dizziness, or mild allergic reactions. Seek medical help if severe allergic reactions occur.

Used for the treatment of bacterial infections, including respiratory infections, urinary tract infections, sinusitis, pneumonia, skin infections, and bronchitis.

Take the medication exactly as prescribed. Do not skip doses or stop early, as it may lead to antibiotic resistance. Consult a doctor before use in case of known allergies to cephalosporins or penicillin.

Common side effects may include nausea, diarrhea, abdominal pain, headache, dizziness, or mild allergic reactions. Seek medical help if severe allergic reactions occur.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation